Barr Cipro authorized generic
Executive Summary
Barr launches authorized generic of Bayer's Cipro under patent settlement. The ciprofloxacin patent expires Dec. 9, 2003, and Bayer is seeking pediatric exclusivity. Firms are negotiating an agreement that could allow Barr to distribute ciprofloxacin during exclusivity period...